Last reviewed · How we verify
NCT06201572
The Value of TOI in Evaluating Renal Function Damage in Hypertensive Emergency Patients
trial testing The relationship between TOI composite index and renal function in hypertensive emergency patients was compared in Hypertensive Emergency in 300 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | The Affiliated Hospital of Hangzhou Normal University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 February 2024 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
Drugs / interventions tested
- The relationship between TOI composite index and renal function in hypertensive emergency patients was compared
Conditions studied
- Hypertensive Emergency — all drugs for Hypertensive Emergency →
Sponsor
The Affiliated Hospital of Hangzhou Normal University
Who can join
Adults 18 to 90, any sex, with Hypertensive Emergency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
TOI was used to measure heart rate, respiration, blood pressure, heart rate variability and psychological stress. At the same time, the patient's urine protein, creatinine, urea nitrogen and other indicators were detected. According to different renal function, they were divided into observation group and control group, and 100 general inpatients with renal insufficiency were selected as positive control group. The relationship between TOI composite index and renal function in hypertensive emergency patients was compared.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06201572
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The Affiliated Hospital of Hangzhou Normal University trials
Trials by the same sponsor.
- NCT07241195 — A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From · not yet recruiting
- NCT07399600 — Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease · NA · not yet recruiting
- NCT07233486 — A Multicenter, Randomized, Crossover Clinical Trial Study of Digital Intelligence Software in Patients With MAFLD · NA · recruiting
- NCT06135584 — Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06201572 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Affiliated Hospital of Hangzhou Normal University
- Last refreshed: 22 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06201572.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing